FDA 483 - Grifols Therapeutics LLC

Grifols Therapeutics, Inc. in Clayton, NC, was inspected and cited for multiple quality system deficiencies. Observations included failures to investigate the root cause of leaking fill lines, inadequate work order investigations, deficient written procedures, and various facility and equipment issues. These findings indicate a need for improved quality oversight and adherence to manufacturing controls.